Clinical efficacy of antiarrhythmic drugs in prevention of sudden coronary death.
D000889:Anti-Arrhythmia Agents / Q000097:blood / Q000627:therapeutic use*; D001073:Aprindine / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000175:diagnosis / Q000188:drug therapy / Q000191:economics; D017023:Coronary Angiography; D001026:Coronary Artery Bypass; D003327:Coronary Disease / Q000150:complications / Q000188:drug therapy* / Q000401:mortality; D003645:Death, Sudden / Q000209:etiology*; D004305:Dose-Response Relationship, Drug; D004562:Electrocardiography; D006801:Humans; D007700:Kinetics; D008801:Mexiletine / Q000097:blood / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy / Q000401:mortality; D010672:Phenytoin / Q000097:blood / Q000627:therapeutic use; D011342:Procainamide / Q000009:adverse effects / Q000627:therapeutic use; D012306:Risk
D000889:Anti-Arrhythmia Agents; D008801:Mexiletine; D001073:Aprindine; D010672:Phenytoin; D011342:Procainamide